MS Sequencing: Part 2 β Treatment initiation
January 12, 2017…ibed more often than orals as the first-choice agent. To date, the few head-to-head studies comparing first-line orals with the injectables, such as the CONFIRM and TENERE trials, have produced equivocal results (Fox et al. N Engl J Med 2012;367:1087-1097; Vermersch et al. Mult Scler 2014;20:705-716). This may help to explain why glatiramer acetate continues to be the most frequently prescribed injectable, despite the fact that it is the only DMT…